loading...| Preferred Name |
Anaplastic large cell lymphoma |
| ID |
http://www.orpha.net/ORDO/Orphanet_98841 |
| alternative_term |
Primary systemic ALCL CD30 positive anaplastic large cell lymphoma ALCL sACL Ki-1 positive anaplastic large cell lymphoma |
| definition |
A rare and aggressive peripheral T-cell non-Hodgkin lymphoma, belonging to the group of CD30-positive lymphoproliferative disorders, which affects lymph nodes and extranodal sites. It is comprised of two sub-types, based on the expression of a protein called anaplastic lymphoma kinase (ALK): ALK positive and ALK negative ALCL. |
| definition_citation |
Orphanet |
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98841 |
| has_age_of_onset |
All ages |
| has_inheritance |
Not applicable |
| hasDbXref |
MeSH:D017728 UMLS:C0206180 ICD-11:2A90.A ICD-11:2A90.B ICD-10:C84.6 ICD-10:C84.7 |
| label |
Anaplastic large cell lymphoma |
| notation |
ORPHA:98841 |
| part_of | |
| prefixIRI |
ORDO:Orphanet_98841 |
| prefLabel |
Anaplastic large cell lymphoma |
| present_in |
Europe AND has_point_prevalence_average_value : 2.0 AND has_point_prevalence_range : 1-9 / 100 000 |
| treeView | |
| subClassOf |